NILOTINIB

Drug action

Nilotinib is a tyrosine kinase inhibitor.

Indications and dose

Newly diagnosed chronic phase Philadelphia chromosome-positive chronic myeloid leukaemia (initiated by a specialist)

By...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×